Why Have Clinical Trials of Antioxidants to Prevent Neurodegeneration Failed? - A Cellular Investigation of Novel Phenothiazine-Type Antioxidants Reveals Competing Objectives for Pharmaceutical Neuroprotection
Crossref DOI link: https://doi.org/10.1007/s11095-016-2068-0
Published Online: 2016-11-28
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ohlow, Maike J.
Sohre, Selina
Granold, Matthias
Schreckenberger, Mathias
Moosmann, Bernd
Funding for this research was provided by:
Interdisciplinary Research Centre for Neurosciences of the University of Mainz
License valid from 2016-11-28